CelltrionGroup provides biosimilar and innovative biopharmaceutical medications to help increase patient access... to advanced therapies around the world. CelltrionGroup offers biologics to about 110 countries, along with more than 30...
CelltrionGroup provides biosimilar and innovative biopharmaceutical medications to help increase patient access... to advanced therapies around the world. CelltrionGroup offers biologics to about 110 countries, along with more than 30 global...
CelltrionGroup Chile is seeking a proactive marketing and sales professional to promote authorized biosimilar products...
CelltrionGroup Chile is seeking a proactive marketing and sales professional to promote authorized biosimilar products...
. CelltrionGroup offers biologics to about 110 countries, along with more than 30 general partners around the world. With hands...## Chile\\_Sales RepresentativeSolicitar: Santiago: Full time: Publicado ayer: JR-00000718Celltrion Group provides...
CelltrionGroup provides biosimilar and innovative biopharmaceutical medications to help increase patient access... to advanced therapies around the world. CelltrionGroup offers biologics to about 110 countries, along with more than 30 global...
CelltrionGroup is seeking a Chile-based Sales Representative in Santiago for a full-time role. You will promote...
## Chile\\_Sales RepresentativeSolicitar: Santiago: Full time: Publicado ayer: JR-CelltrionGroup provides biosimilar... and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. CelltrionGroup...
## Chile\\_Sales RepresentativePresenta candidatura: Santiago: Full time: Offerta pubblicata ieri: JR-CelltrionGroup... around the world. CelltrionGroup offers biologics to about 110 countries, along with more than 30 general partners around the...
around the world. CelltrionGroup offers biologics to about 110 countries, along with more than 30 integral partners around the... around the world, CelltrionGroup has been securing distribution channels and providing patients with biosimilars at affordable...